We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $200M
1-Year Est. Return 12.67%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+12.67%
3 Year Est. Return
+89.15%
5 Year Est. Return
+104.79%
10 Year Est. Return
+863.86%
AUM
$141M
AUM Growth
+$1.24M
Cap. Flow
+$1.1M
Cap. Flow %
0.78%
Top 10 Hldgs %
65.29%
Holding
52
New
6
Increased
8
Reduced
31
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.78%
3 Consumer Discretionary 16.97%
4 Industrials 15.55%
5 Financials 11.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
26
Edwards Lifesciences
EW
$49.4B
$1.34M 0.95%
18,001
-60
-0.3% -$4.62K
TSM icon
27
TSMC
TSM
$2.15T
$1.27M 0.9%
16,989
-249
-1% -$18K
PSQ icon
28
ProShares Short QQQ
PSQ
$777M
$1.1M 0.78%
+14,909
New +$1.07M
SARK icon
29
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$38.6M
$1.04M 0.74%
+6,361
New +$1.17M
TLT icon
30
iShares 20+ Year Treasury Bond ETF
TLT
$46.4B
$1.03M 0.73%
10,390
+4,245
+69% +$428K
AAPL icon
31
Apple
AAPL
$4.84T
$1.03M 0.73%
7,921
+3,029
+62% +$433K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$764K 0.54%
1,999
-301
-13% -$116K
FNV icon
33
Franco-Nevada
FNV
$50.7B
$716K 0.51%
5,245
-900
-15% -$119K
WRB icon
34
W.R. Berkley
WRB
$26.5B
$693K 0.49%
+14,325
New +$691K
EPD icon
35
Enterprise Products Partners
EPD
$83.8B
$666K 0.47%
27,625
-2,925
-10% -$72K
IBB icon
36
iShares Biotechnology ETF
IBB
$10.3B
$623K 0.44%
4,745
-885
-16% -$114K
COST icon
37
Costco
COST
$400B
$595K 0.42%
+1,303
New +$637K
XBI icon
38
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$577K 0.41%
6,950
-1,245
-15% -$101K
VNOM icon
39
Viper Energy
VNOM
$8.93B
$354K 0.25%
+11,150
New +$360K
LAMR icon
40
Lamar Advertising Co
LAMR
$15B
$249K 0.18%
2,634
+27
+1% +$2.5K
HSY icon
41
Hershey
HSY
$34.2B
$228K 0.16%
983
+65
+7% +$15K
DG icon
42
Dollar General
DG
$27.5B
$227K 0.16%
922
+104
+13% +$25.7K
SJB icon
43
ProShares Short High Yield
SJB
$46M
$215K 0.15%
11,300
-68,250
-86% -$1.31M
PPTA
44
Perpetua Resources
PPTA
$2.84B
$163K 0.12%
55,700
-8,900
-14% -$19.3K
STEM icon
45
Stem
STEM
$44.6M
$122K 0.09%
680
-81
-11% -$19.5K
CCJ icon
46
Cameco
CCJ
$39.7B
-20,025
Closed -$489K
CHPT icon
47
ChargePoint
CHPT
$237M
-2,579
Closed -$690K
DBC icon
48
Invesco DB Commodity Index Tracking Fund
DBC
$2B
-20,100
Closed -$526K
EUM icon
49
ProShares Trust Short MSCI Emerging Markets
EUM
$13.3M
-34,775
Closed -$1.07M
LRCX icon
50
Lam Research
LRCX
$339B
-33,800
Closed -$1.69M

Similar funds

Scholtz & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Scholtz & Company held 52 positions worth $141M, up 0.89% from $140M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Scholtz & Company's Q4 2022 filing shows 6 new, 8 increased, 31 reduced and 7 closed positions. Its largest new stake was ProShares Short S&P500: 121,683 shares worth $7.8M. The largest sale was Lam Research, an estimated $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Scholtz & Company's largest Q4 2022 buy was ProShares Short S&P500: 121,683 shares worth $7.8M.
  • Scholtz & Company added most to Northrop Grumman in Q4 2022, an estimated $900K increase.
  • Scholtz & Company's biggest Q4 2022 reduction was ProShares Short High Yield, cutting an estimated $1.31M.
  • Scholtz & Company fully exited Lam Research in Q4 2022, selling an estimated $1.69M.
  • Scholtz & Company's ten largest holdings make up 65% of its $141M portfolio in Q4 2022.
  • Scholtz & Company opened 6 new positions and closed 7 in Q4 2022.
  • Scholtz & Company's portfolio value rose 0.89% quarter-over-quarter to $141M.

Based on Scholtz & Company's 13F filing for Q4 2022, filed 14 Feb 2023.